Oncostatin M limits inflammation and induces repair in the damaged CNS Hasselt University
Multiple sclerosis (MS) is a chronic progressive disorder, which for the time being can not be cured. The existing therapeutic interventions are focused on the first phase of the disease where the immune system is playing a prominent role. Current therapies are therefore only effective in curbing the disease, but no longer work when the patient enters the progressive disease phase. We are looking for new therapeutic targets that can stop or even ...